The stock of Aytu BioPharma Inc (NASDAQ:AYTU) last traded at $2.00, up 34.23% from the previous session.
AYTU stock price is now 43.90% away from the 50-day moving average and 17.01% away from the 200-day moving average. The market capitalization of the company currently stands at $12.34M.
With the price target of $11, Cantor Fitzgerald recently initiated with Overweight rating for Aytu BioPharma Inc (NASDAQ: AYTU). On May 29, 2020, H.C. Wainwright recently initiated its ‘Buy’ rating on the stock quoting a target price of $3
In other news, Disbrow Joshua R., Chief Executive Officer bought 15,000 shares of the company’s stock on Feb 28 ’25. The stock was bought for $19,500 at an average price of $1.30. Upon completion of the transaction, the Chief Executive Officer now directly owns 86,591 shares in the company, valued at $0.17 million. A total of 2.96% of the company’s stock is owned by insiders.
During the past 12 months, Aytu BioPharma Inc has had a low of $0.95 and a high of $3.21. As of last week, the company has a debt-to-equity ratio of 0.65, a current ratio of 1.03, and a quick ratio of 0.87.
The net profit margin was 2.37% and return on equity was 3.29% for AYTU. The company reported revenue of $18.45 million for the quarter, compared to $14.03 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 31.57 percent.
